Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Frankfurt - Delayed Quote • EUR Madrigal Pharmaceuticals, Inc. (YDO1.F) Follow Add holdings 272.00 +7.50 +(2.84%) At close: 9:55:02 PM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for YDO1.F 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: YDO1.F View More All News Press Releases SEC Filings Madrigal Pharmaceuticals to Release First-Quarter 2025 Financial Results and Host Webcast on May 1, 2025 Madrigal Pharmaceuticals Announces Company Founder Rebecca Taub, M.D. to Become Senior Scientific and Medical Advisor; David Soergel, M.D., Appointed Chief Medical Officer Is Madrigal Pharmaceuticals (MDGL) The Most Expensive Stock Insiders Are Dumping In March? Exploring 3 High Growth Tech Stocks in the US Market Madrigal Pharmaceuticals (MDGL): Among the Best Biotech Stocks to Buy According to Billionaires Madrigal Appoints Jacqualyn A. Fouse, Ph.D. to Its Board of Directors Goldman Sachs Says It’s Time to Pull the Trigger on Healthcare Stocks — Here Are 2 Names to Pounce on Now Madrigal Pharmaceuticals price target raised to $239 from $154 at BofA We're Not Worried About Madrigal Pharmaceuticals' (NASDAQ:MDGL) Cash Burn High Growth Tech Stocks In US For February 2025 Madrigal Pharmaceuticals Inc (MDGL) Q4 2024 Earnings Call Highlights: Strong Sales Growth and ... Related Tickers TENX Tenax Therapeutics, Inc. 5.46 +7.06% INSM Insmed Incorporated 70.80 -0.62% PCVX Vaxcyte, Inc. 33.16 +6.08% VRTX Vertex Pharmaceuticals Incorporated 492.42 +0.40% VKTX Viking Therapeutics, Inc. 25.79 +1.22%